- Home
- PDD vs TMO Comparison
PDD vs TMO Comparison
Compare PDD & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDD
- TMO
- Stock Information
- Founded
- PDD 2015
- TMO 1956
- Country
- PDD Ireland
- TMO United States
- Employees
- PDD N/A
- TMO N/A
- Industry
- PDD Business Services
- TMO Industrial Machinery/Components
- Sector
- PDD Consumer Discretionary
- TMO Industrials
- Exchange
- PDD Nasdaq
- TMO Nasdaq
- Market Cap
- PDD 173.5B
- TMO 181.0B
- IPO Year
- PDD 2018
- TMO N/A
- Fundamental
- Price
- PDD $133.85
- TMO $478.02
- Analyst Decision
- PDD Buy
- TMO Buy
- Analyst Count
- PDD 11
- TMO 17
- Target Price
- PDD $131.73
- TMO $587.00
- AVG Volume (30 Days)
- PDD 11.4M
- TMO 1.5M
- Earning Date
- PDD 08-25-2025
- TMO 10-22-2025
- Dividend Yield
- PDD N/A
- TMO 0.36%
- EPS Growth
- PDD N/A
- TMO 7.24
- EPS
- PDD 9.23
- TMO 17.30
- Revenue
- PDD $57,179,362,067.00
- TMO $43,212,000,000.00
- Revenue This Year
- PDD $9.64
- TMO $3.38
- Revenue Next Year
- PDD $15.11
- TMO $4.62
- P/E Ratio
- PDD $14.61
- TMO $27.30
- Revenue Growth
- PDD 19.91
- TMO 2.04
- 52 Week Low
- PDD $87.11
- TMO $385.46
- 52 Week High
- PDD $155.67
- TMO $623.77
- Technical
- Relative Strength Index (RSI)
- PDD 72.93
- TMO 49.59
- Support Level
- PDD $123.77
- TMO $469.14
- Resistance Level
- PDD $135.37
- TMO $486.57
- Average True Range (ATR)
- PDD 3.00
- TMO 11.74
- MACD
- PDD 0.65
- TMO -2.86
- Stochastic Oscillator
- PDD 92.68
- TMO 28.74
About PDD PDD Holdings Inc.
PDD Holdings operates commerce businesses in over 80 countries globally. Its main operations are Pinduoduo, a social commerce platform in China, and Temu, a global e-commerce marketplace. PDD also has a community group purchase business in China. PDD has built a network of sourcing, logistics, and fulfillment capabilities that support its underlying businesses.
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).